Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies

NCT00619879 is registered in ClinicalTrials.gov with Ann & Robert H Lurie Children's Hospital of Chicago as lead sponsor.

NCT NCT00619879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00619879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies
Lead sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Phase
Observational
Overall status
Completed
Start date
March 26, 2007
Completion date
February 7, 2019
Enrollment
81 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, lymphoblastic, acute, leukemia, myelogenous, acute, leukemia, myelogenous, chronic, lymphoma, malignant, myeloproliferative-myelodysplastic diseases